These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31855101)

  • 1. A metabolic pathway for the prodrug nabumetone to the pharmacologically active metabolite, 6-methoxy-2-naphthylacetic acid (6-MNA) by non-cytochrome P450 enzymes.
    Matsumoto K; Hasegawa T; Ohara K; Takei C; Kamei T; Koyanagi J; Takahashi T; Akimoto M
    Xenobiotica; 2020 Jul; 50(7):783-792. PubMed ID: 31855101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of human flavin-containing monooxygenase (FMO) 5 in the metabolism of nabumetone: Baeyer-Villiger oxidation in the activation of the intermediate metabolite, 3-hydroxy nabumetone, to the active metabolite, 6-methoxy-2-naphthylacetic acid
    Matsumoto K; Hasegawa T; Ohara K; Kamei T; Koyanagi J; Akimoto M
    Xenobiotica; 2021 Feb; 51(2):155-166. PubMed ID: 33146575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical power of LLE-HPLC-PDA-MS/MS in drug metabolism studies: identification of new nabumetone metabolites.
    Nobilis M; Mikušek J; Szotáková B; Jirásko R; Holčapek M; Chamseddin C; Jira T; Kučera R; Kuneš J; Pour M
    J Pharm Biomed Anal; 2013 Jun; 80():164-72. PubMed ID: 23584048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro characterization of the cytochrome P450 isoforms involved in the metabolism of 6-methoxy-2-napthylacetic acid, an active metabolite of the prodrug nabumetone.
    Matsumoto K; Nemoto E; Hasegawa T; Akimoto M; Sugibayashi K
    Biol Pharm Bull; 2011; 34(5):734-9. PubMed ID: 21532165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
    Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
    Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of HSD17B12 as an enzyme catalyzing drug reduction reactions through investigation of nabumetone metabolism.
    Ichida H; Fukami T; Kudo T; Mishiro K; Takano S; Nakano M; Morinaga G; Matsui A; Ishiguro N; Nakajima M
    Arch Biochem Biophys; 2023 Mar; 736():109536. PubMed ID: 36724833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hydroxyimine as cytochrome P450-selective prodrug structure.
    Kumpulainen H; Mähönen N; Laitinen ML; Jaurakkajärvi M; Raunio H; Juvonen RO; Vepsäläinen J; Järvinen T; Rautio J
    J Med Chem; 2006 Feb; 49(3):1207-11. PubMed ID: 16451086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbon-carbon bond cleavage in activation of the prodrug nabumetone.
    Varfaj F; Zulkifli SN; Park HG; Challinor VL; De Voss JJ; Ortiz de Montellano PR
    Drug Metab Dispos; 2014 May; 42(5):828-38. PubMed ID: 24584631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gut microbiota metabolizes nabumetone
    Jourova L; Anzenbacher P; Matuskova Z; Vecera R; Strojil J; Kolar M; Nobilis M; Hermanova P; Hudcovic T; Kozakova H; Kverka M; Anzenbacherova E
    Xenobiotica; 2019 Nov; 49(11):1296-1302. PubMed ID: 30794062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetration of the active metabolite of nabumetone into synovial fluid and adherent tissue of patients undergoing knee joint surgery.
    Miehlke RK; Schneider S; Sörgel F; Muth P; Henschke F; Giersch KH; Münzel P
    Drugs; 1990; 40 Suppl 5():57-61. PubMed ID: 2081495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
    Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
    Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Baeyer-Villiger oxidation specifically catalyzed by human flavin-containing monooxygenase 5.
    Lai WG; Farah N; Moniz GA; Wong YN
    Drug Metab Dispos; 2011 Jan; 39(1):61-70. PubMed ID: 20947616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of nabumetone and 6-methoxy-2-naphthylacetic acid in plasma using HPLC with UV and MS detection].
    Nespesná L; Stícha M; Matousková O; Perlík F; Slanar O
    Ceska Slov Farm; 2011 Feb; 60(1):17-24. PubMed ID: 21650014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel injection strategy of flurbiprofen axetil by inhibiting protein binding with 6-methoxy-2-naphthylacetic acid.
    Ogata K; Takamura N; Tokunaga J; Ikeda T; Setoguchi N; Tanda K; Yamasaki T; Nishio T; Kawai K
    Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):179-86. PubMed ID: 25537338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extractionless determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by high-performance liquid chromatography.
    de Jager AD; Hundt HK; Hundt AF; Swart KJ; Knight M; Roberts J
    J Chromatogr B Biomed Sci Appl; 2000 Apr; 740(2):247-51. PubMed ID: 10821411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput LC-MS/MS assay for 6-methoxy-2-naphthylacetic acid, an active metabolite of nabumetone in human plasma and its application to bioequivalence study.
    Patel BN; Sharma N; Sanyal M; Prasad A; Shrivastav PS
    Biomed Chromatogr; 2008 Nov; 22(11):1213-24. PubMed ID: 18651608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution?
    Dandona P; Jeremy JY
    Drugs; 1990; 40 Suppl 5():16-24. PubMed ID: 2081487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nabumetone: therapeutic use and safety profile in the management of osteoarthritis and rheumatoid arthritis.
    Hedner T; Samulesson O; Währborg P; Wadenvik H; Ung KA; Ekbom A
    Drugs; 2004; 64(20):2315-43; discussion 2344-5. PubMed ID: 15456329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of 6-methoxy-2-naphthylacetic acid, a major metabolite of nabumetone, in human plasma by HPLC].
    Qin Y; Zou Y; Liang M; Huang Y; Yu Q
    Hua Xi Yi Ke Da Xue Xue Bao; 1999 Dec; 30(4):452-4. PubMed ID: 11387968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro effects of 6-methoxy-2-naphthylacetic acid, the active metabolite of nabumetone, on rat gastric mucosal eicosanoid synthesis and metabolism.
    Melarange R; Spangler R; Hoult JR
    Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):195-200. PubMed ID: 8931119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.